Published in N Engl J Med on January 04, 1996
Mortality Surveillance of MRFIT Screenees | NCT00005156
Renal Denervation in Chronic Kidney Disease - RDN-CKD Study (RDN-CKD) | NCT04264403
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ (1998) 32.73
The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev (2007) 6.79
Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int (2009) 5.28
Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med (2009) 4.05
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med (2008) 3.71
Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int (2009) 3.58
Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children study. Hypertension (2008) 2.84
Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol (2009) 2.66
Hyperuricemia in childhood primary hypertension. Hypertension (2003) 2.39
Defining incident chronic kidney disease in the research setting: The ARIC Study. Am J Epidemiol (2009) 2.22
Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). J Am Soc Nephrol (2003) 2.21
Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis (2014) 2.16
The state of U.S. living kidney donors. Clin J Am Soc Nephrol (2010) 2.11
Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States. Hypertension (2010) 1.81
Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study. Am J Nephrol (2009) 1.80
Comparison of the Framingham Heart Study hypertension model with blood pressure alone in the prediction of risk of hypertension: the Multi-Ethnic Study of Atherosclerosis. Hypertension (2010) 1.75
Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease. Clin J Am Soc Nephrol (2009) 1.72
Impact of achieved blood pressures on mortality risk and end-stage renal disease among a large, diverse hypertension population. J Am Coll Cardiol (2014) 1.71
Lowering blood pressure reduces renal events in type 2 diabetes. J Am Soc Nephrol (2009) 1.68
Social context as an explanation for race disparities in hypertension: findings from the Exploring Health Disparities in Integrated Communities (EHDIC) Study. Soc Sci Med (2008) 1.63
Central body fat distribution associates with unfavorable renal hemodynamics independent of body mass index. J Am Soc Nephrol (2013) 1.62
Substantial variation in the acceptance of medically complex live kidney donors across US renal transplant centers. Am J Transplant (2008) 1.57
Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis (2008) 1.56
Midlife Blood Pressure and Late-Life GFR and Albuminuria: An Elderly General Population Cohort. Am J Kidney Dis (2015) 1.46
Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis. CMAJ (2013) 1.43
Parental history of premature cardiovascular disease, estimated GFR, and rate of estimated GFR decline: results from the Aerobics Center Longitudinal Study. Am J Kidney Dis (2015) 1.38
Resistant hypertension--its identification and epidemiology. Nat Rev Nephrol (2012) 1.26
High prevalence of chronic kidney disease in Iran: a large population-based study. BMC Public Health (2009) 1.21
Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2008) 1.18
The gap between estimated incidence of end-stage renal disease and use of therapy. PLoS One (2013) 1.16
Characteristics of uninsured Americans with chronic kidney disease. J Gen Intern Med (2009) 1.15
Proteinuria as a predictor of disease progression in children with hypodysplastic nephropathy. Data from the Ital Kid Project. Pediatr Nephrol (2003) 1.15
Low medication adherence and hypertension control among adults with CKD: data from the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis (2010) 1.15
Trends in diabetes, high cholesterol, and hypertension in chronic kidney disease among U.S. adults: 1988-1994 to 1999-2004. Diabetes Care (2008) 1.14
Mechanism of dietary salt-mediated increase in intravascular production of TGF-beta1. Am J Physiol Renal Physiol (2008) 1.13
New therapeutic agents in diabetic nephropathy. Korean J Intern Med (2017) 1.11
Blood pressure, atherosclerosis, and albuminuria in 10,113 participants in the atherosclerosis risk in communities study. J Hypertens (2009) 1.10
Cigarette smoking and the association with glomerular hyperfiltration and proteinuria in healthy middle-aged men. Clin J Am Soc Nephrol (2011) 1.08
Beta-glucans in the treatment of diabetes and associated cardiovascular risks. Vasc Health Risk Manag (2008) 1.06
The relationship of ethnicity to the prevalence and management of hypertension and associated chronic kidney disease. BMC Nephrol (2011) 1.03
Risk factors for progression of chronic kidney disease. Curr Opin Pediatr (2010) 1.03
Target organ damage in African American hypertension: role of APOL1. Curr Hypertens Rep (2012) 1.02
Diabetes mellitus and hypertension: key risk factors for kidney disease. J Natl Med Assoc (2002) 1.00
Time-updated systolic blood pressure and the progression of chronic kidney disease: a cohort study. Ann Intern Med (2015) 0.99
Therapeutic strategies to slow chronic kidney disease progression. Pediatr Nephrol (2008) 0.99
Illicit drug use, hypertension, and chronic kidney disease in the US adult population. Transl Res (2012) 0.96
Incidence of hypertension in Korea: 5-year follow-up study. J Korean Med Sci (2011) 0.96
Home blood pressure monitoring: how good a predictor of long-term risk? Curr Hypertens Rep (2011) 0.95
Renal function in diabetic nephropathy. World J Diabetes (2010) 0.95
Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial. J Hypertens (2007) 0.95
Orthostatic hypotension and incident chronic kidney disease: the atherosclerosis risk in communities study. Hypertension (2010) 0.94
Resistive index predicts renal prognosis in chronic kidney disease: results of a 4-year follow-up. Clin Exp Nephrol (2010) 0.93
Current perspectives on combination therapy in the management of hypertension. Integr Blood Press Control (2013) 0.92
Sympathetic renal innervation and resistant hypertension. Int J Hypertens (2011) 0.92
End-stage renal disease in Taiwan: a case-control study. J Epidemiol (2009) 0.92
The fourth-generation Calcium channel blocker: cilnidipine. Indian Heart J (2013) 0.91
Hypertension, left ventricular hypertrophy and chronic kidney disease. Heart Fail Rev (2011) 0.91
Predictors of progression to chronic dialysis in survivors of severe acute kidney injury: a competing risk study. BMC Nephrol (2014) 0.91
Effect of allopurinol on cardiovascular incidence among hypertensive nephropathy patients: the Gonryo study. Clin Exp Nephrol (2012) 0.91
Long-term renal outcome in patients with malignant hypertension: a retrospective cohort study. BMC Nephrol (2012) 0.91
Progression of pediatric CKD of nonglomerular origin in the CKiD cohort. Clin J Am Soc Nephrol (2015) 0.90
Epidemiology of hypertensive kidney disease. Nat Rev Nephrol (2010) 0.89
Cigarette smoking: an important renal risk factor - far beyond carcinogenesis. Tob Induc Dis (2002) 0.89
Olmesartan/amlodipine: a review of its use in the management of hypertension. Vasc Health Risk Manag (2011) 0.89
Genetic basis of nondiabetic end-stage renal disease. Semin Nephrol (2010) 0.89
Hypertension and obesity and the risk of kidney cancer in 2 large cohorts of US men and women. Hypertension (2014) 0.89
Chronic kidney disease: a new look at pathogenetic mechanisms and treatment options. Pediatr Nephrol (2013) 0.88
Waist circumference, not body mass index, is associated with renal function decline in korean population: hallym aging study. PLoS One (2013) 0.88
Relationship between prehypertension and chronic kidney disease in middle-aged people in Korea: the Korean genome and epidemiology study. BMC Public Health (2012) 0.88
Slowing progression of chronic kidney disease. Kidney Int Suppl (2011) (2013) 0.88
New Generation Calcium Channel Blockers in Hypertensive Treatment. Curr Hypertens Rev (2006) 0.88
Association of BP with Death, Cardiovascular Events, and Progression to Chronic Dialysis in Patients with Advanced Kidney Disease. Clin J Am Soc Nephrol (2015) 0.87
Association between asymptomatic hyperuricemia and new-onset chronic kidney disease in Japanese male workers: a long-term retrospective cohort study. BMC Nephrol (2011) 0.87
Association between body mass index and chronic kidney disease: a population-based, cross-sectional study of a Japanese community. Vasc Health Risk Manag (2009) 0.87
Blood pressure tracking in children and adolescents. Pediatr Nephrol (2013) 0.87
The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol. BMC Nephrol (2013) 0.87
N-acetyltransferase 8, a positional candidate for blood pressure and renal regulation: resequencing, association and in silico study. BMC Med Genet (2008) 0.87
Heart rate as a risk factor for developing chronic kidney disease: longitudinal analysis of a screened cohort. Clin Exp Nephrol (2009) 0.86
Pediatric hypertension: An update on a burning problem. World J Cardiol (2014) 0.86
Renal dysfunction, metabolic syndrome and cardiovascular disease mortality. J Nutr Metab (2010) 0.86
Blood pressure indexes and end-stage renal disease risk in adults with chronic kidney disease. Am J Hypertens (2012) 0.86
Resistant hypertension in nondialysis chronic kidney disease. Int J Hypertens (2013) 0.86
Renal tissue oxygenation in essential hypertension and chronic kidney disease. Int J Hypertens (2013) 0.86
Prevalence, determinants, and management of chronic kidney disease in Karachi, Pakistan - a community based cross-sectional study. BMC Nephrol (2014) 0.86
Therapeutic approaches to slowing the progression of diabetic nephropathy - is less best? Drugs Context (2013) 0.86
Treating hypertension while protecting the vulnerable islet in the cardiometabolic syndrome. J Am Soc Hypertens (2008) 0.85
Blood pressure and human genetic variation in the general population. Curr Opin Cardiol (2010) 0.85
Relationship between chronic kidney disease and metabolic syndrome: current perspectives. Diabetes Metab Syndr Obes (2014) 0.85
Non-pharmacological aspects of blood pressure management: what are the data? Kidney Int (2011) 0.85
Hypertension in hemodialysis patients: an opinion-based update. Semin Dial (2014) 0.85
Risk factors for chronic kidney disease: an update. Kidney Int Suppl (2011) (2013) 0.84
Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHAT. Clin J Am Soc Nephrol (2016) 0.84
Kidney function and tobacco smoke exposure in US adolescents. Pediatrics (2013) 0.84
Antihypertensive effects of dietary protein and its mechanism. Int J Angiol (2010) 0.84
An update on 'progression promoters' in renal diseases. J Natl Med Assoc (2003) 0.84
Summary of the 2007 European Society of Hypertension (ESH) and European Society of Cardiology (ESC) guidelines for the management of arterial hypertension. Vasc Health Risk Manag (2007) 0.84
End-stage renal disease in young black males in a black-white population: longitudinal analysis of the Bogalusa Heart Study. BMC Nephrol (2009) 0.84
Optimizing blood pressure control in patients with chronic kidney disease. Proc (Bayl Univ Med Cent) (2010) 0.83
Metabolic syndrome and risk of progression of chronic kidney disease: a single-center cohort study in Japan. Heart Vessels (2012) 0.83
Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet (1990) 25.12
CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med (2006) 22.76
Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care (1993) 17.66
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation (1989) 9.97
Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies. N Engl J Med (1999) 9.26
Attributes of excellent attending-physician role models. N Engl J Med (1998) 7.87
Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med (1997) 6.31
Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. JAMA (1993) 6.27
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol (1986) 6.27
Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation (2000) 5.41
Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA (1998) 5.37
Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med (2000) 5.11
End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA (1997) 5.09
Current status of hypertension control in an industrial population. JAMA (1972) 5.03
Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med (2000) 4.83
Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med (2001) 4.81
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. Am J Hypertens (1996) 4.66
Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med (1994) 4.64
The effect of bedside case presentations on patients' perceptions of their medical care. N Engl J Med (1997) 4.63
Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med (1993) 4.59
Interleukin-2 therapy in patients with HIV infection. N Engl J Med (2009) 4.38
An evaluation of the Social Security Administration master beneficiary record file and the National Death Index in the ascertainment of vital status. Am J Public Health (1983) 4.36
Socioeconomic differentials in mortality risk among men screened for the Multiple Risk Factor Intervention Trial: I. White men. Am J Public Health (1996) 4.35
Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med (1989) 4.31
Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med (1997) 4.27
Diet, serum cholesterol, and death from coronary heart disease. The Western Electric study. N Engl J Med (1981) 4.01
Hypertension screening of 1 million Americans. Community Hypertension Evaluation Clinic (CHEC) program, 1973 through 1975. JAMA (1976) 3.94
Smoking as "independent" risk factor for suicide: illustration of an artifact from observational epidemiology? Lancet (1992) 3.92
Benefit of a favorable cardiovascular risk-factor profile in middle age with respect to Medicare costs. N Engl J Med (1998) 3.89
Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. JAMA (1992) 3.86
Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA (1999) 3.85
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. Ann Intern Med (2008) 3.68
Artificial heterokaryons of animal cells from different species. J Cell Sci (1966) 3.44
Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med (1992) 3.42
The association of skin color with blood pressure in US blacks with low socioeconomic status. JAMA (1991) 3.29
A delicate subject. Epidemiology (1992) 3.29
Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA (1997) 3.27
Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years. Am Heart J (1984) 3.25
Serum cholesterol. Doing the right thing. Circulation (1993) 3.16
The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. JAMA (1992) 3.01
Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension (2000) 3.01
Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia (2003) 3.00
Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? Arch Intern Med (1991) 2.74
Statistical methods to assess and minimize the role of intra-individual variability in obscuring the relationship between dietary lipids and serum cholesterol. J Chronic Dis (1978) 2.72
Relationship of relative weight and body mass index to 14-year mortality in the Chicago Peoples Gas Company study. J Chronic Dis (1975) 2.71
Diabetes mellitus, race, and socioeconomic status. A population-based study. Ann Epidemiol (1996) 2.71
Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med (1999) 2.69
Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med (2001) 2.69
Relationship of education to major risk factors and death from coronary heart disease, cardiovascular diseases and all causes, Findings of three Chicago epidemiologic studies. Circulation (1982) 2.65
The relationship of education to blood pressure: findings on 40,000 employed Chicagoans. Circulation (1976) 2.64
Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol (1980) 2.62
Adherence and blood-pressure response to hypertension treatment. Lancet (1975) 2.61
Assessment of the association between habitual salt intake and high blood pressure: methodological problems. Am J Epidemiol (1979) 2.56
Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med (1993) 2.55
Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial. Am Heart J (1986) 2.55
Nutritional therapy for high blood pressure. Final report of a four-year randomized controlled trial--the Hypertension Control Program. JAMA (1987) 2.55
Multivariate analysis of the relationship of seven variables to blood pressure: findings of the Chicago Heart Association Detection Project in Industry, 1967-1972. J Chronic Dis (1975) 2.55
Weight and blood pressure. Findings in hypertension screening of 1 million Americans. JAMA (1978) 2.54
Interrelationships of myeloid and lymphoid cells: studies with chromosome-marked cells transfused into lethally irradiated mice. Proc R Soc Lond B Biol Sci (1966) 2.54
Socioeconomic differentials in mortality risk among men screened for the Multiple Risk Factor Intervention Trial: II. Black men. Am J Public Health (1996) 2.45
Alcohol consumption, cardiovascular risk factors, and mortality in two Chicago epidemiologic studies. Circulation (1977) 2.44
Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Proc Natl Acad Sci U S A (1999) 2.44
Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension (2001) 2.42
Alcohol and blood pressure: the INTERSALT study. BMJ (1994) 2.41
Weight-loss experience of black and white participants in NHLBI-sponsored clinical trials. Am J Clin Nutr (1991) 2.39
Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: the Chicago Heart Association Detection Project in Industry. Arch Intern Med (2001) 2.36
Undetected eye disease in a primary care clinic population. Arch Intern Med (1994) 2.32
A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDS. N Engl J Med (1994) 2.32
A piece of my mind. Morning distort. JAMA (1991) 2.28
A prospective study of blood pressure and serum creatinine. Results from the 'Clue' Study and the ARIC Study. JAMA (1993) 2.25
Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study. J Hum Hypertens (2003) 2.25
Depressive symptoms and metabolic control in African-Americans with type 2 diabetes. Diabetes Care (2000) 2.23
Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension (1989) 2.18
End-stage renal disease attributable to diabetes mellitus. Ann Intern Med (1994) 2.16
Reciprocal translocations. Br Med Bull (1969) 2.15
Race and end-stage renal disease. Socioeconomic status and access to health care as mediating factors. Arch Intern Med (1995) 2.12
Legume consumption and risk of coronary heart disease in US men and women: NHANES I Epidemiologic Follow-up Study. Arch Intern Med (2001) 2.08
The benefits of tight glycemic control in diabetes mellitus. For the many or for the few? Arch Intern Med (1995) 2.06
Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA (1997) 2.06